Corrigendum to: HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome
Corrigendum to: HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome [Cardiovasc Res 2013;99:44-54]
Source: Cardiovascular Research - Category: Cardiology Source Type: research